Citadel Advisors
CUE icon

Citadel Advisors’s Cue Biopharma CUE Stock Holding History

Citadel Advisors’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-337
Closed -$9.2K – 12912
2025
Q1 		$9.2K Sell
337
-23
-6% -$854 ﹤0.01% 13613
2024
Q4 		$11.8K Sell
360
-120
-25% -$4.51K ﹤0.01% 13531
2024
Q3 		$10.9K Buy
480
+53
+12% +$1.15K ﹤0.01% 13182
2024
Q2 		$15.9K Sell
427
-3
-0.7% -$148 ﹤0.01% 12813
2024
Q1 		$24.4K Sell
430
-313
-42% -$22.1K ﹤0.01% 12866
2023
Q4 		$58.9K Buy
743
+243
+49% +$17.4K ﹤0.01% 11610
2023
Q3 		$34.5K Buy
500
+53
+12% +$5.17K ﹤0.01% 12165
2023
Q2 		$48.9K Sell
447
-513
-53% -$60.3K ﹤0.01% 11825
2023
Q1 		$103K Buy
960
+757
+373% +$72.2K ﹤0.01% 11227
2022
Q4 		$17.4K Sell
203
-254
-56% -$23.2K ﹤0.01% 13252
2022
Q3 		$31K Sell
457
-280
-38% -$24.1K ﹤0.01% 11891
2022
Q2 		$55K Sell
737
-280
-28% -$32.8K ﹤0.01% 11865
2022
Q1 		$149K Sell
1,017
-250
-20% -$53K ﹤0.01% 11859
2021
Q4 		$430K Buy
1,267
+474
+60% +$183K ﹤0.01% 10041
2021
Q3 		$347K Buy
793
+100
+14% +$34.9K ﹤0.01% 10734
2021
Q2 		$242K Sell
693
-827
-54% -$321K ﹤0.01% 11765
2021
Q1 		$556K Buy
1,520
+570
+60% +$235K ﹤0.01% 9445
2020
Q4 		$357K Buy
950
+97
+11% +$38.8K ﹤0.01% 8763
2020
Q3 		$385K Buy
+853
New +$492K ﹤0.01% 7727

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $1.84B AUM 19.34% 1-Year Est. Return

Citadel Advisors's CUE Position: Q3 2024 in Review

Citadel Advisors sold out of Cue Biopharma (CUE) in Q3 2024, closing a stake of 2,776 shares — an estimated $60.1K sold.

Citadel Advisors first reported a position in CUE in Q1 2020 and held it in 15 quarters. The position peaked at $6.69M in Q2 2020. 50 funds tracked by Wall St. Rank hold CUE as of Q3 2024.

  • Citadel Advisors reported no remaining Cue Biopharma position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 2,776 Cue Biopharma shares in Q3 2024, an estimated $60.1K.
  • Citadel Advisors first reported a position in Cue Biopharma in Q1 2020 and held it in 15 quarters.
  • Citadel Advisors's Cue Biopharma position peaked at $6.69M in Q2 2020.
  • 50 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.